Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-22-008047

Exec. Director, Finance - PAO sold 2,300 shares at $17.20 ($39,560)

  • Exec. Director, Finance - PAO acquired 2,300 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Jones Michael L · Exec. Director, Finance - PAO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-03-01 Exercise or conversion : show line 1 in the form +2,300 $4.73 $10,879 13,498 D
2022-03-01 Sale : show line 2 in the form −2,300 $17.20 $39,560 11,198 D
Open-market sales · 2,300 sh · avg $17.20 · $39,560

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-01 Exercise or conversion : show line 3 in the form Emp. Stock Option (Right to Buy) −2,300 0 D
Loading xslF345X03/form4.xml…